Question to the Department for Science, Innovation & Technology:
To ask the Secretary of State for Science, Innovation and Technology, which Departments were involved in discussions with Astra-Zeneca on the expansion of the vaccine production plant at Speke Merseyside.
A cross-Government approach is taken to support the UK’s Life Sciences sector. This was the case for Government’s work to explore AstraZeneca’s potential investment in Speke, which involved No10, HM Treasury, the Department for Science, Innovation and Technology, the Department of Health and Social Care and the Department for Business and Trade.